Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004183429 | SCV003685238 | uncertain significance | not specified | 2021-08-13 | criteria provided, single submitter | clinical testing | The c.311C>T (p.A104V) alteration is located in exon 2 (coding exon 2) of the NACAD gene. This alteration results from a C to T substitution at nucleotide position 311, causing the alanine (A) at amino acid position 104 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003427629 | SCV004156876 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | NACAD: BP4, BS2 |